Search results for cancer

“In later stage cancer, autophagy may be reactivated to help cells in their pursuit to continue gaining a foothold in the otherwise hostile environment of the body.”

“The majority of glutamine administered orally is taken up by the liver and gut, with little ending up in the bloodstream. Dr. D'Agostino discourages supplementing with glutamine for patients with cancers of the gastrointestinal tract and even recommends they avoid high glutamine containing foods.”

“In addition to being a medical doctor, Dr. Attia has done research on the role of regulatory T cells in cancer regression and other immune-based therapies for cancer. Regulatory T cells have also been, in the past, referred to as suppressor T cells because of their role in actually attenuating or reducing the inflammatory response.”

“Although human trials are lacking, some animal research suggests that sulforaphane and its byproducts protect against bladder cancer. In this clip, Dr. Jed Fahey discusses the effects of urinary excretion of sulforaphane byproducts.”

“Although human trials are lacking, some animal research suggests that sulforaphane and its byproducts protect against bladder cancer. But the mechanisms by which sulforaphane exerts its cancer-preventive effects may backfire in existing cancers.”

“Emerging research suggests that caloric restriction mimetics, when used in conjunction with chemotherapy, enhance the anti-cancer immune response that makes chemotherapy have lasting effects.”

“However, mTOR activation in peripheral tissues, such as the vascular system, has been linked to atherosclerosis and cancer. Exercise resolves this issue by directing leucine toward muscle tissue, ensuring mTOR activation occurs where it’s beneficial.”

“There is so much to say when we talk about the NRF2 pathway and isothiocyanates like sulforaphane that we had to pack it into 47 minutes and break it into a few key sections. Key sections: For a more in-depth breakdown click the timeline link at the top of this page!”

“His groundbreaking work has been recognized in numerous awards from organizations in the fields of science, medicine, pharmacology, and cancer research. Dr. Kroemer completed his medical degree and postdoctoral training at the Collège de France, Nogent-sur-Marne.”